Chief Executive Officer of the Serum Institute of India (SII) Adar Poonawalla on Thursday said the company will be providing 20,000 to 30,000 Ebola vaccines to Uganda for trials.

Speaking to the reporters here on the sidelines of annual general meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN), Poonawalla said if the trials are successful, the firm will see whether the product should be stockpiled for future outbreaks.